PHATHOM PHARMACEUTICALS, INC. Capital Expenditures Incurred but Not yet Paid
PHATHOM PHARMACEUTICALS, INC. (PHAT) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-07-30
- PHATHOM PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $0.00.
- PHATHOM PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- PHATHOM PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$51.00K, a 737.50% decline year-over-year.
- PHATHOM PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $42.00K.
- PHATHOM PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PHATHOM PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $8.00K, a 55.56% decline from fiscal 2023.
- PHATHOM PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $18.00K, a 86.96% decline from fiscal 2022.
- PHATHOM PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $138.00K, a 6800.00% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $0.00 10-Q · filed 2026-07-30 | -$51.00K derived: sum of 3 quarters · filed 2026-07-30 | -$9.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $0.00 10-Q · filed 2026-04-30 | -$51.00K derived: sum of 2 quarters · filed 2026-04-30 | -$9.00K derived: sum of 3 quarters · filed 2026-04-30 | -$44.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.00K derived: sum of 2 quarters · filed 2026-02-26 | -$44.00K derived: sum of 3 quarters · filed 2026-07-30 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $7.00K derived: sum of 2 quarters · filed 2026-07-30 | $51.00K 10-Q · filed 2025-10-30 | $59.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $9.00K 10-Q · filed 2026-07-30 | $17.00K derived: sum of 3 quarters · filed 2026-07-30 | $7.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $44.00K 10-Q · filed 2026-04-30 | $52.00K derived: sum of 2 quarters · filed 2026-04-30 | $42.00K derived: sum of 3 quarters · filed 2026-04-30 | $45.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.00K derived: sum of 3 quarters · filed 2026-02-26 | $8.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$7.00K derived: sum of 2 quarters · filed 2025-10-30 | $0.00 10-Q · filed 2025-10-30 | |
| 2024-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $10.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $7.00K 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $18.00K 10-K · filed 2025-03-06 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $134.00K derived: sum of 3 quarters · filed 2024-08-08 | $122.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 10-Q/A · filed 2024-06-14 | $134.00K derived: sum of 2 quarters · filed 2024-06-14 | $122.00K derived: sum of 3 quarters · filed 2024-06-14 | $18.00K derived: sum of 4 quarters · filed 2024-06-14 |
| 2022-12-31 | $134.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-06-14 | $122.00K derived: sum of 2 quarters · filed 2024-06-14 | $18.00K derived: sum of 3 quarters · filed 2024-06-14 | $138.00K 10-K/A · filed 2024-06-14 |
| 2022-09-30 | -$12.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-09 | -$116.00K derived: sum of 2 quarters · filed 2023-08-10 | $4.00K 10-Q/A · filed 2022-11-09 | -$3.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-06-30 | -$104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $16.00K 10-Q · filed 2023-08-10 | $9.00K derived: sum of 3 quarters · filed 2023-08-10 | $15.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $120.00K 10-Q · filed 2023-05-10 | $113.00K derived: sum of 2 quarters · filed 2023-05-10 | $119.00K derived: sum of 3 quarters · filed 2023-05-10 | $101.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$7.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-02-28 | -$1.00K derived: sum of 2 quarters · filed 2023-02-28 | -$19.00K derived: sum of 3 quarters · filed 2023-02-28 | $2.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $6.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-09 | -$12.00K derived: sum of 2 quarters · filed 2022-11-09 | $9.00K 10-Q/A · filed 2022-11-09 | $115.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $3.00K 10-Q · filed 2022-08-02 | $109.00K derived: sum of 3 quarters · filed 2022-08-02 | $128.00K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $21.00K 10-Q · filed 2022-05-10 | $127.00K derived: sum of 2 quarters · filed 2022-05-10 | $146.00K derived: sum of 3 quarters · filed 2022-05-10 | $146.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $125.00K derived: sum of 2 quarters · filed 2022-03-01 | $125.00K derived: sum of 3 quarters · filed 2022-03-01 | $145.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $19.00K derived: sum of 2 quarters · filed 2021-11-08 | $39.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $20.00K 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $20.00K 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | $339.00K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |